Adiposity and cancer risk: new mechanistic insights from epidemiology
Open accessThe DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
Abstract
Excess body adiposity, commonly expressed as body mass index (BMI), is a risk factor for many common adult cancers. Over the past decade, epidemiological data have shown that adiposity-cancer risk associations are specific for gender, site, geographical population, histological subtype and molecular phenotype. The biological mechanisms underpinning these associations are incompletely understood but need to take account of the specificities observed in epidemiology to better inform future prevention strategies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Systematic reviews on insulin-like growth factor or adiposity and cancer risk took laboratory, animal, and human evidence into account to judge the plausibility of different mechanisms [40,101].”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“based on epidemiological and other evidence, obesity probably increases the risk of several cancers [101,103]”
From COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology (2019) · cites this paper as [101]
In the citing paper
“Epidemiology studies have provided evidence for an association between obesity-related metabolic and inflammatory factors, including changes in insulin-like growth factor 1 signaling, adipokines, sex hormones, and systemic inflammation, and CRC risk.80”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [80]
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Genetics of Food Intake Self-Regulation in Childhood: Literature Review and Research Opportunities
Faith, M. S., Carnell, S., & Kral, T. V. E. (2013) · Human Heredity · doi:10.1159/000353879 · Cited by 7,601
Renehan, A. G., Tyson, M., Egger, M., Heller, R. F., & Zwahlen, M. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60269-x · Cited by 5,219
Self-citationAdipokines in inflammation and metabolic disease
Ouchi, N., Parker, J. L., Lugus, J. J., & Walsh, K. (2011) · Nature Reviews Immunology · doi:10.1038/nri2921 · Cited by 4,625
Functional interactions between the gut microbiota and host metabolism
Tremaroli, V., & Bäckhed, F. (2012) · Nature · doi:10.1038/nature11552 · Cited by 4,387
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
European Guidelines for Obesity Management in Adults
Yumuk, V., Tsigos, C., Fried, M., Schindler, K., Busetto, L., Micic, D., & Toplak, H. (2015) · Obesity Facts · doi:10.1159/000442721 · Cited by 3,432
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Cited by
Items 101–200 of 678
A new role for extracellular vesicles: how small vesicles can feed tumors' big appetite
Lazar, I., Clement, E., Attané, C., Muller, C., & Nieto, L. (2018) · Journal of Lipid Research · doi:10.1194/jlr.r083725 · Cited by 65
Body composition and cancer survival: a narrative review
Bradshaw, P. T. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02470-0 · Cited by 71
“…between survival outcomes and fat mass stems from the understanding that excess adiposity is a risk factor for a number of high-burden cancers [4], the plausible biological mechanisms that may link it to cancer survival [5 – 8], and its relationships with other high-burden comorbidities…”
BackgroundEarly-life obesity and adulthood colorectal cancer risk: a meta-analysis
Garcia, H., & Song, M. (2019) · Revista Panamericana de Salud Pública · doi:10.26633/rpsp.2019.3 · Cited by 65
Intrapancreatic fat, pancreatitis, and pancreatic cancer
Lilly, A. C., Astsaturov, I. A., & Golemis, E. A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04855-z · Cited by 69
“Adiposity is associated with a tumor-promoting function for many types of cancer, based on both systemic and localized effects, delivered through multiple mechanisms [96].”
BackgroundAdipose-derived stromal/stem cells from different adipose depots in obesity development
Silva, K. R., & Baptista, L. S. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i3.147 · Cited by 67
Warner, A. B., & McQuade, J. L. (2019) · Current Oncology Reports · doi:10.1007/s11912-019-0814-2 · Cited by 63
Role of inflammation in obesity-related breast cancer
Crespi, E., Bottai, G., & Santarpia, L. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.11.004 · Cited by 63
Hidayat, K., Du, X., & Shi, B. (2018) · Obesity Reviews · doi:10.1111/obr.12705 · Cited by 67
Seyednasrollah, F. S., Mäkelä, J., Pitkänen, N., Juonala, M., Hutri‐Kähönen, N., Lehtimäki, T. J., Viikari, J. S. A., Kelly, T. N., Li, C., Bazzano, L., et al. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.116.001554 · Cited by 62
Body mass index and colorectal cancer risk: A Mendelian randomization study
Suzuki, S., Goto, A., Nakatochi, M., Narita, A., Yamaji, T., Sawada, N., Katagiri, R., Iwagami, M., Hanyuda, A., Hachiya, T., et al. (2021) · Cancer Science · doi:10.1111/cas.14824 · Cited by 66
Moraes, J. A., Encarnação, C. C., Franco, V. A., Botelho, L. G. X., Rodrigues, G. P., Ramos-Andrade, I., Barja‐Fidalgo, C., & Renovato‐Martins, M. (2021) · Cancers · doi:10.3390/cancers13133328 · Cited by 64
Pastor‐Barriuso, R., Fernández, M. F., Castaño‐Vinyals, G., Whelan, D. R., Pérez‐Gómez, B., Llorca, J., Villanueva, C. M., Guevara, M., Molina-Molina, J.-M., Artacho‐Cordón, F., et al. (2016) · Environmental Health Perspectives · doi:10.1289/ehp157 · Cited by 60
“…alcohol intake, obesity, and use of hormone therapy, exert their effects, at least in part, by modifying the time and intensity of the exposure of the mammary gland to steroidal hormones (Brown and Hankinson 2015; HilakiviClarke et al. 2013; MacMahon 2006; Renehan et al. 2015; Seitz et al. 2012).”
BackgroundInfluentialZhang, I., Cui, Y., Amiri, A., Ding, Y., Campbell, R. E., & Maysinger, D. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.12.008 · Cited by 64
The Obesity-Breast Cancer Conundrum: An Analysis of the Issues
Matthews, S. B., & Thompson, H. J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060989 · Cited by 64
His, M., Dartois, L., Fagherazzi, G., Boutten, A., Dupré, T., Mesrine, S., Boutron‐Ruault, M., Clavel‐Chapelon, F., & Dossus, L. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0832-4 · Cited by 66
Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
Smith, L. K., Arabi, S., Lelliott, E. J., McArthur, G. A., & Sheppard, K. E. (2020) · Cancers · doi:10.3390/cancers12061583 · Cited by 64
“Furthermore, there is a growing body of evidence that adipocytes (fat cells) via directly influencing cancer cell metabolism promote tumor growth [23] and cytokines released due to obesity induced chronic low-level inflammation also promotes cancer cell proliferation and survival [24].”
BackgroundMalvi, P., Chaube, B., Singh, S. V., Mohammad, N., Pandey, V., Vijayakumar, M. V., Radhakrishnan, R. M., Vanuopadath, M., Nair, S. S., Nair, B. G., et al. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0162-8 · Cited by 55
How to Manage the Obese Patient With Cancer
Renehan, A. G., Harvie, M., Cutress, R. I., Leitzmann, M., Pischon, T., Howell, S., & Howell, A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1899 · Cited by 57
“© 2016 by American Society of Clinical Oncology INTRODUCTION Excess body weight, commonly expressed as elevated body mass index (BMI; overweight and obesity), is an established risk factor for several incident adult cancers.(1) The International Agency for Research on Cancer(2) lists 13 obesity-related cancers, which…”
BackgroundSelf-citationAssociation between Body Mass Index, C-Reactive Protein Levels, and Melanoma Patient Outcomes
Fang, S., Wang, Y., Dang, Y., Gagel, A., Ross, M. I., Gershenwald, J. E., Cormier, J. N., Wargo, J. A., Haydu, L. E., Davies, M. A., et al. (2017) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2017.04.007 · Cited by 58
“Obesity is a known risk factor for cancer development (Arnold et al., 2016; Basen-Engquist and Chang, 2011; Renehan et al., 2015) and death (Calle et al., 2003).”
BackgroundJiao, L., Chen, L., White, D. L., Tinker, L. F., Chlebowski, R. T., Horn, L. V., Richardson, P., Lane, D. S., Sangi‐Haghpeykar, H., & El‐Serag, H. B. (2017) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djx117 · Cited by 63
“The DM intervention could have contributed to improved insulin resistance and immune function (26), suppressed chronic inflammatory tumor microenvironment, or changed the gut microbiome (27,28).”
BackgroundJoshi, P. A., Waterhouse, P. D., Kasaian, K., Fang, H., Gulyaeva, О. N., Sul, H. S., Boutros, P. C., & Khokha, R. (2019) · Nature Communications · doi:10.1038/s41467-019-09748-z · Cited by 59
Aarestrup, J., Bjerregaard, L. G., Meyle, K. D., Pedersen, D. C., Gjærde, L. K., Jensen, B. W., & Baker, J. L. (2020) · International Journal of Obesity · doi:10.1038/s41366-020-0523-9 · Cited by 59
“There are putative pathophysiological mechanisms plausibly linking adult body size and later cancer risks, including increased bioavailability of endogenous sex hormones, insulin and insulin-like growth factor-1 levels and inflammatory processes [68, 69].”
BackgroundAbbruzzese, J. L., Andersen, D. K., Borrebaeck, C. A. K., Chari, S. T., Costello, E., Cruz‐Monserrate, Z., Eibl, G., Engleman, E. G., Fisher, W. E., Habtezion, A., et al. (2018) · Pancreas · doi:10.1097/mpa.0000000000001037 · Cited by 58
Fontvieille, E., Viallon, V., Recalde, M., Córdova, R., Jansana, A., Peruchet‐Noray, L., Lennon, H., Heath, A. K., Aune, D., Christakoudi, S., et al. (2023) · BMC Medicine · doi:10.1186/s12916-023-03114-z · Cited by 65
“While a high BMI, which is indicative of overweight or obesity, is a recognised risk factor for certain cancers in the general population [3, 37–39], the differences in cancer risk among population groups affected by CMD remained poorly understood [18].”
BackgroundAMPK as a mediator of tissue preservation: time for a shift in dogma?
Langer, H. T., Rohm, M., Goncalves, M. D., & Sylow, L. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-00992-y · Cited by 61
“These effects might explain why disrupted glucose metabolism 72,235–237 and hyperinsulinaemia 238–241 are strong risk factors for cancer, cancer recurrence and death from cancer 242 .”
Pham, D., Pun, N. T., & Park, P. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12860 · Cited by 56
Sedentary behaviour in relation to ovarian cancer risk: a systematic review and meta-analysis
Biller, V. S., Leitzmann, M., Sedlmeier, A., Berger, F. F., Ortmann, O., & Jochem, C. (2021) · European Journal of Epidemiology · doi:10.1007/s10654-020-00712-6 · Cited by 38
Associations of early life and adulthood adiposity with risk of epithelial ovarian cancer
Huang, T., Tworoger, S. S., Willett, W. C., Stampfer, M. J., & ROSNER, B. A. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy546 · Cited by 53
Zhi, X., Kuang, X., Liu, K., & Li, J. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.918330 · Cited by 59
Doerner, S. K., Reis, E. S., Leung, E. S., Ko, J. S., Heaney, J. D., Berger, N. A., Lambris, J. D., & Nadeau, J. H. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0153 · Cited by 58
“Obesity is an increasingly important risk factor for many cancers (1, 2).”
Wilkerson, A. D., Gentle, C. K., Ortega, C. B., & Al‐Hilli, Z. (2024) · Healthcare · doi:10.3390/healthcare12040462 · Cited by 59
“Lastly, obesity is a strong contributor to metabolic syndrome, which promotes insulin resistance and hyperinsulinemia, increasing breast cancer risk and mitogenicity in breast tissue [24–26].”
BackgroundBuas, M. F., He, Q., Johnson, L., Onstad, L., Levine, D., Thrift, A. P., Gharahkhani, P., Palles, C., Lagergren, J., Fitzgerald, R. C., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-311622 · Cited by 54
Chu, Y., Wang, Y., Peng, W., Xu, L., Liu, M., Li, J., Hu, X., Li, Y., Zuo, J., & Ye, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.04.121 · Cited by 52
on behalf of the Taskforce Team of the Obesity Fact Sheet of the Korean Society for the Study of Obesity, Lee, K. R., Seo, M. H., Han, K., Jung, J.-H., & Hwang, I. C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0214-7 · Cited by 56
German, M. N., Lutz, M. K., Pickhardt, P. J., Bruce, R. J., & Said, A. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001260 · Cited by 55
Dimou, N. L., Papadimitriou, N., Mariosa, D., Johansson, M., Brennan, P., Peters, U., Chanock, S. J., Purdue, M. P., Bishop, D. T., Gago-Domínguez, M., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33338 · Cited by 56
“have investigated the association between circulating adiponectin concentration and cancer risk with inverse relationships sometimes reported for endometrial, colorectal, renal cell carcinoma (RCC) and pancreatic cancer.(3,7-10) Epidemiological studies that examined the association between circulating leptin concentra…”
BackgroundSong, M., & Chan, A. T. (2017) · Current Colorectal Cancer Reports · doi:10.1007/s11888-017-0389-y · Cited by 57
Pham, D., Raut, P. K., Pandit, M., Chang, J., Katila, N., Choi, D., Jeong, J., & Park, P. (2020) · Cancers · doi:10.3390/cancers12030613 · Cited by 53
“A large body of clinical epidemiological evidence has indicated the adiposity–cancer associations in which obesity has been considered as a significant risk factor for cancer initiation as well as a substantial driver of tumor progression [49,50].”
BackgroundNatural Killer Cells: Friend or Foe in Metabolic Diseases?
Li, Y., Wang, F., İmani, S., Tao, L., Deng, Y., & Cai, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.614429 · Cited by 58
Adipocytokines and disease progression in endometrial cancer: a systematic review
Ray, I., Meira, L. B., Michael, A., & Ellis, P. E. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-10002-6 · Cited by 58
“In obese women, adipose tissue secretes less adiponectin, which is an anti-inflammatory adipokine, and more inflammatory adipokines such as leptin and visfatin, creating an inflammatory micro-environment that stimulates a cascade of downstream inflammatory pathways that may have mitogenic, anti-apoptotic and angiogeni…”
BackgroundBarra, C. D., Khalil, M., Mat, A., O’Donnell, C., Shaamile, F., Brennan, K., O'Shea, D. B., & Hogan, A. E. (2023) · Obesity · doi:10.1002/oby.23772 · Cited by 55
“A major contributor to obesity’s burden on health is its striking and strong association with numerous chronic diseases, including type 2 diabetes mellitus (T2DM), cardiovascular disease, and many types of cancer [3, 4].”
BackgroundImplantation of engineered adipocytes suppresses tumor progression in cancer models
Nguyen, H. P., An, K., Ito, Y., Kharbikar, B. N., Sheng, R. R., Paredes, B., Murray, E., Pham, K., Brück, M., Zhou, X., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-024-02551-2 · Cited by 61
“There have been numerous mechanisms proposed to explain how WAT is linked to cancer development and progression, including chronic inflammation, hyperinsulinemia, steroid hormones and adipokines 108–114 .”
Waist circumference and risk of breast cancer in Korean women: A nationwide cohort study
Lee, K. R., Hwang, I. C., Han, K., Jung, J.-H., & Seo, M. H. (2017) · International Journal of Cancer · doi:10.1002/ijc.31180 · Cited by 53
“Thus, the positive WC–BC association observed in premenopausal women cannot be explained by the sex hormone hypothesis.(31) This conclusion is further supported by the finding that central obesity is associated with an increased risk of estrogen receptor-negative BC in premenopausal women.”
ResultAdipose Tissue Distribution and Survival Among Women with Nonmetastatic Breast Cancer
Bradshaw, P. T., Feliciano, E. M. C., Prado, C. M. M., Alexeeff, S., Albers, K. B., Chen, W. Y., & Caan, B. J. (2019) · Obesity · doi:10.1002/oby.22458 · Cited by 52
“VAT is a source of endogenous estrogen and proinflammatory cytokines, and it may decrease synthesis of sex hormone-binding globulin (6,7).”
BackgroundAssociation between triglyceride glucose index and risk of cancer: A meta-analysis
Wang, H., Yan, F., Cui, Y., Chen, F., Wang, G., & Cui, W. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1098492 · Cited by 58
Ruan, G., Deng, L., Xie, H., Shi, J., Liu, X., Zheng, X., Chen, Y., Lin, S., Zhang, H., Liu, C., et al. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00332-8 · Cited by 51
“Inflammatory cytokines, including TNF-α, IL-6, and prostaglandin E2, may promote the development of breast cancer by promoting cell proliferation and cell cycle progression [53, 54].”
BackgroundEstimating the Influence of Obesity on Cancer Risk: Stratification by Smoking Is Critical
Song, M., & Giovannucci, E. L. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.67.6916 · Cited by 49
High visceral fat percentage is associated with poor outcome in endometrial cancer
Mauland, K. K., Eng, Ø., Ytre‐Hauge, S., Tangen, I. L., Berg, A., Salvesen, H. B., Salvesen, Ø. O., Krakstad, C., Trovik, J., Høivik, E. A., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21917 · Cited by 53
“The visceral fat exerts distinct endocrine activity, which is thought to contribute to its increased pathogenic potential [10].”
Dai, M., Yang, B., Chen, J., Liu, F., Zhou, Y., Zhou, Y., Xu, Q., Jiang, S., Zhao, S., Li, X., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.024 · Cited by 49
Hepatic manifestations of women with polycystic ovary syndrome
Chen, M., & Ho, H. (2016) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.03.003 · Cited by 51
Mizuno, S., Isayama, H., Nakai, Y., Yoshikawa, T., Ishigaki, K., Matsubara, S., Yamamoto, N., Ijichi, H., Tateishi, K., Tada, M., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000833 · Cited by 52
“Moreover, hyperinsulinemia and systemic inflammation associated with adipokines are reportedly key players in obesity-related carcinogenesis.(32) Peripancreatic VAT is also reported to be associated with inflammation and carcinogenesis in the pancreas.”
BackgroundRaut, P. K., Choi, D. Y., Kim, S. H., Hong, J. T., Kwon, T. K., Jeong, J. H., & Park, P. (2017) · Oncotarget · doi:10.18632/oncotarget.22684 · Cited by 48
Pais, R., & Maurel, T. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10061161 · Cited by 52
Review of Mendelian Randomization Studies on Ovarian Cancer
Guo, J.-Z., Xiao, Q., Gao, S., Li, X., Wu, Q., & Gong, T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.681396 · Cited by 59
“While accumulating research suggests that obesity presents an important risk factor for development of OC (61, 62), the underlying molecular mechanisms are not fully understood.”
BackgroundHermann, P., Gál, V., Kóbor, I., Kirwan, C. B., Kovács, P., Kitka, T., Lengyel, Z., Bálint, E., Varga, B., Csekő, C., et al. (2019) · NeuroImage: Clinical · doi:10.1016/j.nicl.2019.101803 · Cited by 46
“Overweight and obesity are associated with a number of negative cognitive and health outcomes, including increased risk for heart disease (Eckel, 1997), cancer (Renehan et al., 2015), depression (Ha et al.”
BackgroundZhou, B., Jiang, X., She, Q., & Ding, Y. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14276 · Cited by 51
“47 Additionally, another crucial factor in the development of cancer in MASLD patients could be dysfunction of gut microbiota.”
Body mass index and risk of colorectal cancer according to tumor lymphocytic infiltrate
Hanyuda, A., Ogino, S., Qian, Z. R., Nishihara, R., Song, M., Mima, K., Inamura, K., Masugi, Y., Wu, K., Meyerhardt, J. A., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30122 · Cited by 48
“microenvironment.(36) As inflammation and immunity have vastly complex roles, an accumulation of hypothesis-driven and exploratory studies with different sets of biological markers in multiple populations might provide a better picture of the relationship between adiposity and colorectal carcinogenesis.”
BackgroundAparicio, T., Ducreux, M. P., Faroux, R., Barbier, E., Manfrédi, S., Lecomte, T., Etienne, P.-L., Bedenne, L., Bennouna, J., Phelip, J., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.03.031 · Cited by 46
“Other hormones, such as insulin and insulin-like growth factor 1 (IGF1), have controversial effects on the development of colorectal cancer [3].”
InfluentialLinking type 2 diabetes and gynecological cancer: an introductory overview
Anastasi, E., Filardi, T., Tartaglione, S., Lenzi, A., Angeloni, A., & Morano, S. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0982 · Cited by 53
“A decreased amount of SHBG results in an increased amount of bioavailable testosterone and estrogen, subsequently promoting carcinogenesis in the endometrium [47].”
BackgroundTenvooren, I., Jenks, M. Z., Rashid, H., Cook, K. L., Mühlemann, J. K., Sistrunk, C., Holmes, J., Wang, K., Bonin, K., Hodges, K. B., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0687-8 · Cited by 46
Hosgood, H. D., Gunter, M. J., Murphy, N., Rohan, T. E., & Strickler, H. D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00103 · Cited by 47
Abdominal and gluteofemoral size and risk of liver cancer: The liver cancer pooling project
Florio, A. A., Campbell, P. T., Zhang, X., Zeleniuch‐Jacquotte, A., Wactawski‐Wende, J., Smith‐Warner, S. A., Sinha, R., Simon, T. G., Sesso, H. D., Schairer, C., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32760 · Cited by 46
“Visceral fat is metabolically active and releases substantial amounts of growth factors, inflammatory markers, free fatty acids (which contribute to insulin resistance), locally produced estrogen and adipokines, which might contribute to cancer development.(44,45) Only visceral, and not subcutaneous, adipose tissue ha…”
BackgroundSelf-citationGluba-Brzózka, A., Rysz, J., Ławiński, J., & Franczyk, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063404 · Cited by 55
Lynch, B. M., & Leitzmann, M. F. (2017) · Current Epidemiology Reports · doi:10.1007/s40471-017-0119-7 · Cited by 48
da Silva, M., Weiderpass, E., Licaj, I., Lissner, L., & Rylander, C. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0240-5 · Cited by 49
Nutritional Status and Diet in Cancer Prevention
Bail, J. R., Meneses, K., & Demark‐Wahnefried, W. (2016) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2016.05.004 · Cited by 47
Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives
Kasiappan, R., & Rajarajan, D. (2017) · Advances in Nutrition · doi:10.3945/an.117.015800 · Cited by 44
Warburg Effect Metabolism Drives Neoplasia in a Drosophila Genetic Model of Epithelial Cancer
Eichenlaub, T., Villadsen, R., Freitas, F. C. D. P., Andrējeva, D., Aldana, B. I., Nguyen, T., Petersen, O. W., Gorodkin, J., Herranz, H., & Cohen, S. M. (2018) · Current Biology · doi:10.1016/j.cub.2018.08.035 · Cited by 47
Cardiometabolic Risk Factors and Benign Gynecologic Disorders
AlAshqar, A., Patzkowsky, K. E., Afrin, S., Wild, R. A., Taylor, H. S., & Borahay, M. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000718 · Cited by 46
Drummond, A. E., Swain, C. T. V., Brown, K. A., Dixon‐Suen, S. C., Boing, L., van Roekel, E. H., Moore, M. M., Gaunt, T. R., Milne, R. L., English, D. R., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0438 · Cited by 46
“Elevated levels of sex steroid hormones have been shown to be associated with increased risk of breast cancer in observational studies (1, 4).”
BackgroundObesity, Fat Distribution and Risk of Cancer in Women and Men: A Mendelian Randomisation Study
Loh, N. Y., Wang, W., Noordam, R., & Christodoulides, C. (2022) · Nutrients · doi:10.3390/nu14245259 · Cited by 52
“To date, four main mechanisms have been proposed to link adiposity and cancer [9,11,12].”
BackgroundLay, S. L., Rome, S., Loyer, X., & Nieto, L. (2021) · FASEB BioAdvances · doi:10.1096/fba.2020-00147 · Cited by 44
Obesity, diabetes, and cancer: epidemiology, pathophysiology, and potential interventions
Mesquita, L. D. A., Wayerbacher, L. F., Schwartsmann, G., & Gerchman, F. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000647 · Cited by 52
“Ovarian hyperandrogenism leading to chronic anovulation, and consequently decreased progesterone levels, also contributes to the development of endometrial cancer (due to the unopposed estrogen effect) and may explain the decreased incidence of premenopausal breast cancer (13,62).”
BackgroundCentral Adiposity and Subsequent Risk of Breast Cancer by Menopause Status
Houghton, S. C., Eliassen, A. H., Tamimi, R. M., Willett, W. C., ROSNER, B. A., & Hankinson, S. E. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa197 · Cited by 46
Cigarette Smoking and Estrogen-Related Cancer
Baron, J. A., Nichols, H. B., Anderson, C., & Safe, S. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-1803 · Cited by 50
His, M., Gunter, M. J., Keski‐Rahkonen, P., & Rinaldi, S. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02754 · Cited by 45
“4,5 Improved understanding of these biologic mechanisms has led to investigations of potential risk-reducing strategies.”
BackgroundFibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer
Chakraborty, D., Benham, V., Bullard, B. A., Kearney, T. J., Hsia, H. C., Gibbon, D. G., Demireva, E. Y., Lunt, S. Y., & Bernard, J. J. (2017) · Oncogene · doi:10.1038/onc.2017.278 · Cited by 42
“The carcinogenic impact of having excess adipose tissue is profound but exactly how adiposity affects carcinogenesis hasn’t been fully uncovered (1, 2).”
Jensen, B. W., Gamborg, M., Gögenür, I., Renehan, A. G., Sørensen, T. I. A., & Baker, J. L. (2017) · European Journal of Epidemiology · doi:10.1007/s10654-017-0289-0 · Cited by 44
“Potential mechanisms linking adiposity to colon cancer include altered secretion of hormones including leptin, adiponectin and insulin like growth factor 1 (IGF-1), exposure to a chronic state of low-grade inflammation [30], and local ectopic fat situated around organs which may affect the tumor microenvironment [30].”
BackgroundSelf-citationA review for clinicians: Prostate cancer and the antineoplastic properties of metformin
Hankinson, S. J., Fam, M. M., & Patel, N. N. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.10.009 · Cited by 41
Role of PTEN in Oxidative Stress and DNA Damage in the Liver of Whole-Body Pten Haplodeficient Mice
Bankoglu, E. E., Tschopp, O., Schmitt, J., Burkard, P., Jahn, D., Geier, A., & Stopper, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166956 · Cited by 48
Himbert, C., Ose, J., Delphan, M., & Ulrich, C. M. (2017) · Nutrition Research · doi:10.1016/j.nutres.2016.12.004 · Cited by 38
Renehan, A. G., Pegington, M., Harvie, M., Sperrin, M., Astley, S., Brentnall, A. R., Howell, A., Cuzick, J. M., & Evans, D. G. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0807-9 · Cited by 57
Self-citationObesity, weight gain, and ovarian cancer risk in African American women
Bandera, E. V., Qin, B., Moorman, P. G., Alberg, A. J., Barnholtz‐Sloan, J. S., Bondy, M. L., Coté, M. L., Funkhouser, E. M., Peters, E. S., Schwartz, A. G., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30115 · Cited by 39
“Biomarkers of systemic inflammation, such as C-reactive protein (CRP), tumor necrosis factor (TNF), interleukin-1b (IL-1b), IL-6 and IL-18 have also been shown to increase as adiposity increases.(9) Leptin and some of these pro-inflammatory cytokines are also associated with immune suppression.”
BackgroundResultInfluentialEffect of obesity on bladder cancer and renal cell carcinoma incidence and survival
Gild, P., Ehdaie, B., & Kluth, L. A. (2017) · Current Opinion in Urology · doi:10.1097/mou.0000000000000425 · Cited by 43
Romieu, I. I., Amadou, A., & Chajès, V. (2017) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.17002263 · Cited by 54
Morphological and Functional Changes in the Peritumoral Adipose Tissue of Colorectal Cancer Patients
Zoico, E., Rizzatti, V., Darra, E., Budui, S. L., Franceschetti, G., Vinante, F., Pedrazzani, C., Guglielmi, A., Manzoni, G. D., Mazzali, G., et al. (2017) · Obesity · doi:10.1002/oby.22008 · Cited by 44
“Several systemic mechanisms have been proposed to explain this epidemiological association as the production of different adipokines, determining a state of low-grade inflammation and conditions of insulin resistance (3-6).”
BackgroundRitter, A., Louwen, F., & Yuan, J. (2018) · Obesity Reviews · doi:10.1111/obr.12716 · Cited by 40
Childhood body mass index trajectories, adult-onset type 2 diabetes, and obesity-related cancers
Jensen, B. W., Aarestrup, J., Blond, K., Jørgensen, M. E., Renehan, A. G., Vistisen, D., & Baker, J. L. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac192 · Cited by 40
Self-citationObesity as a tumour development triggering factor
Budny, A., Grochowski, C., Kozłowski, P., Kolak, A., Kamińska, M., Kukiełka-Budny, B., Abramiuk, M., & Burdan, F. (2019) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/100664 · Cited by 45
Secretan, B., Dossus, L., Marant-Micallef, C., & His, M. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2019.04.008 · Cited by 53
Diabetes and Cancer: Metabolic Association, Therapeutic Challenges, and the Role of Natural Products
Talib, W. H., Mahmod, A. I., Abuarab, S. F., Hasen, E., Munaim, A. A., Haif, S. K., Ayyash, A. M., Khater, S. H., Al-Yasari, I. H., & Kury, L. T. A. (2021) · Molecules · doi:10.3390/molecules26082179 · Cited by 41
“Obesity promotes tumorigenesis according to evolving studies [88,89] stressing that almost 80% of T2DM cases are associated with obesity and overweight [90].”
BackgroundRole of adipose tissue in melanoma cancer microenvironment and progression
Zoico, E., Darra, E., Rizzatti, V., Tebon, M., Franceschetti, G., Mazzali, G., Rossi, A. P., Fantin, F., & Zamboni, M. M. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.218 · Cited by 43
Jabo, B., Lin, A. C., Aljehani, M. A., Ji, L. N., Morgan, J. W., Selleck, M. J., Kim, H. Y., & Lum, S. S. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6663-7 · Cited by 38
Exosomal microRNA remodels the tumor microenvironment
Jiang, X., Hu, S., Liu, Q., Qian, C., Liu, Z., & Luo, D. (2017) · PeerJ · doi:10.7717/peerj.4196 · Cited by 40
He, W., Jiang, C., Liu, L., Yin, C., Rong, Y., Hu, W., Yang, L., Wang, L., Jin, Y., Lin, X., et al. (2020) · Oral Oncology · doi:10.1016/j.oraloncology.2020.104771 · Cited by 37
Kedia-Mehta, N., Tobin, L. M., Zaiatz-Bittencourt, V., Pisarska, M. M., Barra, C. D., Choi, C., Elamin, E., O'Shea, D. B., Gardiner, C. M., Finlay, D. K., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005047 · Cited by 38
Christodoulatos, G. S., Antonakos, G., Karampela, Ι., Psallida, S., Stratigou, T., Vallianou, N. G., Lekka, A., Μαρίνου, Ι., Vogiatzakis, E., Kokoris, S. I., et al. (2021) · Biomolecules · doi:10.3390/biom11111609 · Cited by 42
“In line with previous reported associations, circulating omentin-1 was linked to the presence of Mets and its severity, which is related to an increased occurrence of BC in postmenopausal women [31,66,67].”
ResultVitamin D deficiency: a potential risk factor for cancer in obesity?
Migliaccio, S., Nisio, A. D., Magno, S., Romano, F., Barrea, L., Colao, A. M. L., Muscogiuri, G., & Savastano, S. (2022) · International Journal of Obesity · doi:10.1038/s41366-021-01045-4 · Cited by 39
Liu, Y. L., Saraf, A., Catanese, B. P., Lee, S. M., Zhang, Y., Connolly, E. P., & Kalinsky, K. M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4507-y · Cited by 37
“androgens to estrogen by aromatase—a process known as aromatization, which suggests that this association may be more pronounced in HR?tumors [34, 35].”
InfluentialDe Ridder, J., Julián-Almárcegui, C., Mullee, A., Rinaldi, S., Van Herck, K., Vicente-Rodríguez, G., & Huybrechts, I. (2016) · Cancer Causes & Control · doi:10.1007/s10552-015-0709-y · Cited by 36
“This theory is increasingly relevant for the development of breast cancer as the amount of fat in the breast is proportional to the total body fat mass [28].”
Background
Metadata
- Authors
- Renehan, A. G., Zwahlen, M., & Egger, M.
- Affiliations
- Manchester Academic Health Science Centre (GB)
- University of Bern (CH)
- Corresponding author
- Renehan, Andrew G.
- Venue
- Nature Reviews Cancer
- Published
- 2015-07-24
- Volume
- 15
- Issue
- 8
- Pages
- 484-498
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1685808974
- Cited by
- 654
- References
- 173
- Citations by year
- 2026: 40 · 2025: 57 · 2024: 71 · 2023: 64 · 2022: 55 · 2021: 69 · 2020: 54 · 2019: 58 · 2018: 54 · 2017: 68 · 2016: 56 · 2015: 7
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- green
- boris.unibe.ch
- Licence
- cc-by-nc
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Institute for Cancer Research
- Cancer Research UK
- Medical Research Council (MR/K006665/1, MC_PC_13042)
- Economic and Social Research Council (ES/F029721/1, ES/J010014/1)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- obesity, adiposity, cancer risk, body mass index, sex differences, tumor location, histological subtypes, molecular phenotypes, biological mechanisms, cancer prevention
- MeSH terms
- Animals, Humans, Inflammation, Neoplasms, Obesity, Risk Factors, Body Mass Index, Incidence, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.